Department of Gastroenterology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Department of Pharmacology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Expert Rev Gastroenterol Hepatol. 2022 Mar;16(3):297-305. doi: 10.1080/17474124.2022.2047649. Epub 2022 Mar 7.
Comparative data on percutaneous catheter drainage (PCD) vs EUS-guided drainage (EUS-D) for management of symptomatic walled-off-necrosis (WON), specially infected WON with/without organ failure(OF) is limited.
Patients with symptomatic WON were divided into two groups of PCD and EUS-D, depending on the modality of drainage. Resolution of OF, adverse events, and other outcome measures were recorded. The two modalities were compared among infected WON sub-cohort and also degree of solid component (SC).
218 patients (175 males; 80.3%) were included who underwent either PCD (n = 102) or EUS-D (n = 116). Clinical success was significantly higher in the EUS-D group (92.1% vs 64.6%; p < 0.0001) and even for infected WON (n = 128) (p = 0.004), with higher (p = 0.007) and faster (p < 0.0001) OF resolution. Other outcome measures including mortality were significantly higher in the PCD group. Among subgroups, PCD with >40% SC had the worst clinical success/OF resolution rates, while EUS-D with <40% SC had the best outcomes.
EUS-D should be preferred over PCD in the management of WON, infected or otherwise, for higher clinical success, and higher/faster resolution of OF. PCD should be avoided in WON with>40% SC.
关于经皮导管引流(PCD)与超声内镜引导引流(EUS-D)治疗症状性隔离坏死(WON),尤其是感染性 WON 伴/不伴器官衰竭(OF)的比较数据有限。
根据引流方式,将有症状性 WON 的患者分为 PCD 组和 EUS-D 组。记录 OF 缓解、不良事件和其他结局指标。在感染性 WON 亚组和固体成分(SC)程度上比较两种方法。
共纳入 218 例患者(男性 175 例,80.3%),分别接受 PCD(n=102)或 EUS-D(n=116)治疗。EUS-D 组临床成功率显著更高(92.1% vs 64.6%;p<0.0001),即使对于感染性 WON(n=128)也是如此(p=0.004),OF 缓解的成功率更高(p=0.007)、速度更快(p<0.0001)。其他结局指标包括死亡率在 PCD 组中显著更高。在亚组中,SC>40%的 PCD 临床成功率/OF 缓解率最差,而 SC<40%的 EUS-D 则有最佳结局。
EUS-D 应优于 PCD 用于治疗 WON,无论是否感染,以获得更高的临床成功率和更快的 OF 缓解。对于 SC>40%的 WON,应避免使用 PCD。